Skip to Main Content

Author Details

Hardy Kornfeld
University of Massachusetts Chan Medical School
1982
182
58
PMIDPaper TitleJournal TitlePublished Year
37386883Circulating Biomarkers, Fraction of Exhaled Nitric Oxide, and Lung Function in Patients With Human Immunodeficiency Virus and Tuberculosis.J Infect Dis2024
36627027Longitudinal trends in glycated hemoglobin during and after tuberculosis treatment.Diabetes Res Clin Pract2023
37730757Glycerol contributes to tuberculosis susceptibility in male mice with type 2 diabetes.Nat Commun2023
37354752Effect of prediabetes on tuberculosis treatment outcomes: A study from South India.Diabetes Metab Syndr2023
36814914Chitinase and indoleamine 2, 3-dioxygenase are prognostic biomarkers for unfavorable treatment outcomes in pulmonary tuberculosis.Front Immunol2023
36737697Lung function and collagen 1a levels are associated with changes in 6 min walk test distance during treatment of TB among HIV-infected adults: a prospective cohort study.BMC Pulm Med2023
36424864Impact of Undernutrition on Tuberculosis Treatment Outcomes in India: A Multicenter, Prospective, Cohort Analysis.Clin Infect Dis2023
34711538Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study.Eur Respir J2022
35352112Heightened Microbial Translocation Is a Prognostic Biomarker of Recurrent Tuberculosis.Clin Infect Dis2022
34984435Whole Genome Sequencing Assessing Impact of Diabetes Mellitus on Tuberculosis Mutations and Type of Recurrence in India.Clin Infect Dis2022
35168250Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection.Diabetes Care2022
32766812Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis.Clin Infect Dis2021
33531400Sirtuin 3 Downregulation in <i>Mycobacterium tuberculosis</i>-Infected Macrophages Reprograms Mitochondrial Metabolism and Promotes Cell Death.mBio2021
33884278Diabetes Mellitus and Tuberculosis Treatment Outcomes in Pune, India.Open Forum Infect Dis2021
34867953Acute Phase Proteins Are Baseline Predictors of Tuberculosis Treatment Failure.Front Immunol2021
33997311Effect of anti-tuberculosis treatment on the systemic levels of tissue inhibitors of metalloproteinases in tuberculosis - Diabetes co-morbidity.J Clin Tuberc Other Mycobact Dis2021
33413293Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis.BMC Pulm Med2021
31552412Declines in Lung Function After Antiretroviral Therapy Initiation in Adults With Human Immunodeficiency Virus and Tuberculosis: A Potential Manifestation of Respiratory Immune Reconstitution Inflammatory Syndrome.Clin Infect Dis2020
31751447A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis.Clin Infect Dis2020
31955202Impact of Diabetes and Low Body Mass Index on Tuberculosis Treatment Outcomes.Clin Infect Dis2020
33067434Metformin enhances anti-mycobacterial responses by educating CD8+ T-cell immunometabolic circuits.Nat Commun2020
33258908Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.JAMA Netw Open2020
31472402Heterogeneity in the cytokine profile of tuberculosis - diabetes co-morbidity.Cytokine2020
31242296Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis.Clin Infect Dis2020
30427060Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity.Immunology2019
31796883Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis.Sci Rep2019
31818258Systemic RAGE ligands are upregulated in tuberculosis individuals with diabetes co-morbidity and modulated by anti-tuberculosis treatment and metformin therapy.BMC Infect Dis2019
31271354Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity.Elife2019
31315698Tuberculosis and diabetes: from bench to bedside and back.Int J Tuberc Lung Dis2019
31279779mTORC2/Akt activation in adipocytes is required for adipose tissue inflammation in tuberculosis.EBioMedicine2019
31632923Plasma Eicosanoid Levels in Tuberculosis and Tuberculosis-Diabetes Co-morbidity Are Associated With Lung Pathology and Bacterial Burden.Front Cell Infect Microbiol2019
30523163Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins.Eur Respir J2019
29491034Tuberculosis and lung damage: from epidemiology to pathophysiology.Eur Respir Rev2018
29862941A dual purpose for household contact investigations: preventing TB disease and improving diabetes outcomes.Int J Tuberc Lung Dis2018
30076042Empirical treatment with non-anti-tuberculosis antibiotics decreased microbiological detection in cervical tuberculous lymphadenitis.Diagn Microbiol Infect Dis2018
30045688Elevated levels of matrix metalloproteinases reflect severity and extent of disease in tuberculosis-diabetes co-morbidity and are predominantly reversed following standard anti-tuberculosis or metformin treatment.BMC Infect Dis2018
29884247Enlisting the Host to Fight TB.Chest2018
30089723IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation.JCI Insight2018
30355404Convergence of non-communicable diseases and tuberculosis: a two-way street?Int J Tuberc Lung Dis2018
29580276Indicators for prediction of Mycobacterium tuberculosis positivity detected with bronchoalveolar lavage fluid.Infect Dis Poverty2018
27717783Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.J Infect2017
28434937Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 2: Underlying Biologic Mechanisms.Chest2017
28434936Defining a Research Agenda to Address the Converging Epidemics of Tuberculosis and Diabetes: Part 1: Epidemiology and Clinical Management.Chest2017
28476627"The Impact of Mycobacterium tuberculosis Immune Evasion on Protective Immunity: Implications for TB Vaccine Design" - Meeting report.Vaccine2017
28707004Host sirtuin 1 regulates mycobacterial immunopathogenesis and represents a therapeutic target against tuberculosis.Sci Immunol2017
28910369Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment.PLoS One2017
28515464Systems Immunology of Diabetes-Tuberculosis Comorbidity Reveals Signatures of Disease Complications.Sci Rep2017
26752596Diabetes Is Associated with Worse Clinical Presentation in Tuberculosis Patients from Brazil: A Retrospective Cohort Study.PLoS One2016
27783671NK-CD11c+ Cell Crosstalk in Diabetes Enhances IL-6-Mediated Inflammation during Mycobacterium tuberculosis Infection.PLoS Pathog2016
27865391Modulation of dendritic cell and monocyte subsets in tuberculosis-diabetes co-morbidity upon standard tuberculosis treatment.Tuberculosis (Edinb)2016
  • 1 - 50 of 182

Recommended Authors

Eusondia Arnett
Texas Biomedical Research Institute
Career Start Year 2011
Number of shared co-authors 2
Laura Campisi
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 0
April K Randhawa
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Marc Veldhoen
Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa
Career Start Year 2005
Number of shared co-authors 0
Ho Namkoong
Keio University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Sugata Roy
RIKEN Center for Integrative Medical Sciences
Career Start Year 2004
Number of shared co-authors 0
Alan H Diercks
Seattle Children's Research Institute
Career Start Year 2002
Number of shared co-authors 1
Michelle E Armstrong
Trinity College Dublin
Career Start Year 2001
Number of shared co-authors 0
Antje Blumenthal
Frazer Institute, The University of Queensland
Career Start Year 2001
Number of shared co-authors 1
Sarah A Stanley
University of California berkeley
Career Start Year 2001
Number of shared co-authors 0
Reto Guler
International Centre for Genetic Engineering and Biotechnology
Career Start Year 1999
Number of shared co-authors 0
Alejandra Solache
Trudeau Institute
Career Start Year 1998
Number of shared co-authors 1
Charles S Dela Cruz
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 0
Cristina M Tato
Institute of Immunity, Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Onn Min Kon
Chest & Allergy clinic, Imperial College Healthcare NHS Trust, St Mary's Hospital
Career Start Year 1996
Number of shared co-authors 1
Deborah A Lewinsohn
Oregon Health and Science University
Career Start Year 1996
Number of shared co-authors 3
Rodrigo Andres Floto
University of Cambridge
Career Start Year 1995
Number of shared co-authors 0
Mahdad Noursadeghi
University College London
Career Start Year 1992
Number of shared co-authors 0
Clay B Marsh
West Virginia University School of Medicine
Career Start Year 1992
Number of shared co-authors 1
Akiko Iwasaki
Yale University
Career Start Year 1990
Number of shared co-authors 0
Mikhail A Gavrilin
The Ohio State University, Wexner Medical Center
Career Start Year 1988
Number of shared co-authors 1
Albert C Shaw
Yale School of Medicine, Yale University
Career Start Year 1987
Number of shared co-authors 1
Wayne Conrad Liles
University of Washington
Career Start Year 1986
Number of shared co-authors 0
William Henry Boom
Case Western Reserve University and University Hospitals Cleveland Medical Center
Career Start Year 1985
Number of shared co-authors 3
Maria Laura Gennaro
Public Health Research Institute, Rutgers New Jersey Medical School
Career Start Year 1980
Number of shared co-authors 7
Mark D Wewers
The Ohio State University College of Medicine
Career Start Year 1980
Number of shared co-authors 1
Alan Aderem
Seattle Children's Research Institute
Career Start Year 1979
Number of shared co-authors 1
Christopher B Wilson
Drukier Institute for Children's Health
Career Start Year 1976
Number of shared co-authors 1
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1969
Number of shared co-authors 1
Luis J Montaner
Wistar Institute
Career Start Year 1958
Number of shared co-authors 2

Collaborators

Jinhee Lee
University of Massachusetts Medical School
Co-authored papers 19
Drew Weissman
Co-authored papers 4
Larry S Schlesinger
Texas Biomedical Research Institute
Co-authored papers 3
Teresa Repasy
University of California berkeley
Co-authored papers 3
Julie A McMurry
University of Colorado - Anschutz Medical Campus
Co-authored papers 2
Joel D Ernst
University of California san francisco
Co-authored papers 2
Katherine A Fitzgerald
Co-authored papers 2
William D Martin
EpiVax Inc.
Co-authored papers 2
Anne S De Groot
University of Georgia
Co-authored papers 2
Daniel Rivera
Center for Natural Products Research, University of Havana
Co-authored papers 2
Leonard D Shultz
The Jackson Laboratory Cancer Center
Co-authored papers 1
David M Lewinsohn
Oregon Health and Science University
Co-authored papers 1
Andrew J Olive
College of Osteopathic Medicine, Michigan State University
Co-authored papers 1
Michele A Kutzler
Drexel University College of Medicine
Co-authored papers 1
David R Sherman
University of Washington
Co-authored papers 1
Avrum Spira
Boston University School of Medicine
Co-authored papers 1
Leonard Moise
EpiVax Inc.
Co-authored papers 1
Andrew V Kossenkov
The Wistar Institute
Co-authored papers 1
Mary Susan Burnett
Co-authored papers 1
Alessandro Sette
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 1
Stephen E Epstein
Co-authored papers 1
Sandy D Der
Toronto General Research Institute, University Health Network
Co-authored papers 1
David W Andrews
Sunnybrook Research Institute, University of Toronto
Co-authored papers 1
Elizabeth J Carter
Warren Alpert School of Medicine at Brown University
Co-authored papers 1
David B Weiner
Wistar Institute
Co-authored papers 1
Leroy Hood
Center for Phenomic Health, The Buck Institute for Research on Aging
Co-authored papers 1
Helder I Nakaya
Co-authored papers 1
Randall H Friedline
Co-authored papers 1
Michael B Brenner
Co-authored papers 1
Beth A Sullivan
Duke University School of Medicine
Co-authored papers 1
Release 1.2